MOLN (MOLN) Stock Price & Analysis
MOLN (MOLN) rose 0.00% to USD 4.35 as of September 9, 2026 at 13:25 UTC, according to Nexqual real-time market data.
MOLN last closed at USD 4.35; the session ranged USD 4.35–4.35 on volume of 154 shares. Market capitalization is —, with a 52-week range of USD 3.53–5.36 (NMS). Source: Nexqual, September 9, 2026 at 13:25 UTC.
Key Statistics (as of September 9, 2026 at 13:25 UTC)
| Price | USD 4.35 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 4.35 |
| Open | USD 4.35 |
| Day Range | USD 4.35 – 4.35 |
| 52-Week Range | USD 3.53 – 5.36 |
| Volume | 154 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (MOLN)
Nexqual's technical model rates MOLN "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 13:25 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 54 (neutral) |
| vs SMA50 | Above (USD 4.13) |
| MACD | 0.07 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | USD 2.07 | ▼ 0.96% |
| RLYB | Rallybio Corporation | USD 16.61 | ▼ 1.57% |
| DSGN | Design Therapeutics, Inc. | USD 15.23 | ▲ 1.33% |
| GLUE | Monte Rosa Therapeutics, Inc. | USD 14.27 | ▼ 0.76% |
| PHVS | Pharvaris N.V. | USD 37.84 | ▲ 6.11% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 13:25 UTC. This page is informational and not investment advice.